Search research articles
Contact Us
Filters
Showing results (1151-1160 of 1,472) with videos related to
Page
of 148
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 22, 2004
Gemcitabine and ISIS-2503 for patients with locally advanced or metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II trial
Steven R Alberts, Mark Schroeder, Charles Erlichman, et al.
British Journal of Cancer
|
May 12, 2005
Plucked human hair as a tissue in which to assess pharmacodynamic end points during drug development studies
D R Camidge, K R Randall, J R Foster, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
March 20, 2024
Impact of COVID-19-related restricted family presence policies on Canadian pediatric intensive care unit clinicians: a qualitative study
Molly J Ryan, Laurie Lee, Sara Drisdelle, et al.
The Oncologist
|
January 26, 2019
A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)
Thorvardur R Halfdanarson, Nathan R Foster, George P Kim, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 15, 2014
Matrix metalloproteinase 9-mediated shedding of syndecan 4 in response to tumor necrosis factor α: a contributor to endothelial cell glycocalyx dysfunction
Raina Ramnath, Rebecca R Foster, Yan Qiu, et al.
Journal of Hepatology
|
June 25, 2017
Safety of the 2D/3D direct-acting antiviral regimen in HCV-induced Child-Pugh A cirrhosis - A pooled analysis
Fred Poordad, David R Nelson, Jordan J Feld, et al.
Insects
|
April 30, 2021
Nootkatone Is an Effective Repellent against <i>Aedes aegypti</i> and <i>Aedes albopictus</i>
Taylor C Clarkson, Ashley J Janich, Irma Sanchez-Vargas, et al.
Journal of Viral Hepatitis
|
February 6, 2023
The tolerability of sofosbuvir/velpatasvir for 12 weeks in patients treated in the ASTRAL 1, 2 and 3 studies: A pooled safety analysis
Ira M Jacobson, Stefan Bourgeois, Phillipe Mathurin, et al.
Immunology
|
May 1, 2008
Widespread natural variation in murine natural killer T-cell number and function
Stacia L Rymarchyk, Hayden Lowenstein, Jana Mayette, et al.
Alimentary Pharmacology & Therapeutics
|
June 1, 2019
The association between hepatocellular carcinoma and direct-acting anti-viral treatment in patients with decompensated cirrhosis
Ali Jibran Mecci, Polychronis Kemos, Clifford Leen, et al.
Page
of 148
Search research articles
Search
Showing results (1151-1160 of 1,472) with videos related to
Sort By:
Page
of 148
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 22, 2004
Gemcitabine and ISIS-2503 for patients with locally advanced or metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II trial
Steven R Alberts, Mark Schroeder, Charles Erlichman, et al.
British Journal of Cancer
|
May 12, 2005
Plucked human hair as a tissue in which to assess pharmacodynamic end points during drug development studies
D R Camidge, K R Randall, J R Foster, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
March 20, 2024
Impact of COVID-19-related restricted family presence policies on Canadian pediatric intensive care unit clinicians: a qualitative study
Molly J Ryan, Laurie Lee, Sara Drisdelle, et al.
The Oncologist
|
January 26, 2019
A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)
Thorvardur R Halfdanarson, Nathan R Foster, George P Kim, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 15, 2014
Matrix metalloproteinase 9-mediated shedding of syndecan 4 in response to tumor necrosis factor α: a contributor to endothelial cell glycocalyx dysfunction
Raina Ramnath, Rebecca R Foster, Yan Qiu, et al.
Journal of Hepatology
|
June 25, 2017
Safety of the 2D/3D direct-acting antiviral regimen in HCV-induced Child-Pugh A cirrhosis - A pooled analysis
Fred Poordad, David R Nelson, Jordan J Feld, et al.
Insects
|
April 30, 2021
Nootkatone Is an Effective Repellent against <i>Aedes aegypti</i> and <i>Aedes albopictus</i>
Taylor C Clarkson, Ashley J Janich, Irma Sanchez-Vargas, et al.
Journal of Viral Hepatitis
|
February 6, 2023
The tolerability of sofosbuvir/velpatasvir for 12 weeks in patients treated in the ASTRAL 1, 2 and 3 studies: A pooled safety analysis
Ira M Jacobson, Stefan Bourgeois, Phillipe Mathurin, et al.
Immunology
|
May 1, 2008
Widespread natural variation in murine natural killer T-cell number and function
Stacia L Rymarchyk, Hayden Lowenstein, Jana Mayette, et al.
Alimentary Pharmacology & Therapeutics
|
June 1, 2019
The association between hepatocellular carcinoma and direct-acting anti-viral treatment in patients with decompensated cirrhosis
Ali Jibran Mecci, Polychronis Kemos, Clifford Leen, et al.
Page
of 148